Delivery Order SPE2DR25D3101-SPE2DR26F5S42
Award Date 12/10/25
Potential Completion Date 12/11/25
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,895.51 by the Defense Logistics Agency (DLA) on December 8, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections with a completion date of December 9, 2025. The award is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 22, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. This firm fixed-price delivery order, valued at $21,693.46, represents a non-competitive set-aside procurement and is scheduled for completion by October 23, 2025. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $16,124.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on December 3, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injections with a ceiling value of $3,623.56. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 4, 2025. The contract is performed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,459.86 by the Defense Logistics Agency on September 15, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL). The contract is classified as a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at the company's location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a $1,107.42 firm fixed price delivery order on December 3, 2025, by the Defense Logistics Agency (DLA) for Zepbound 12.5 mg/0.5 ml pen injections. This is a non-set-aside competitive award with an ultimate completion date of December 4, 2025 and place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $36,921.15 by the Defense Logistics Agency (DLA) on November 12, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 18, 2025, for Zepbound 7.5 mg/0.5 mL pen injections with a ceiling value of $1,134.73. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with ultimate completion scheduled for November 19, 2025. The order will be fulfilled at AmerisourceBergen's Conshohocken facility...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,575.48 by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $12,150.18 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on November 17, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of November 18, 2025. The pharmaceutical product will be delivered to the contracting location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...